Your browser doesn't support javascript.
loading
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study.
Baroncini, Damiano; Ghezzi, Angelo; Guaschino, Clara; Moiola, Lucia; Filippi, Massimo; Ianniello, Antonio; Pozzilli, Carlo; Lanzillo, Roberta; Brescia-Morra, Vincenzo; Margoni, Monica; Gallo, Paolo; Callari, Graziella; Grimaldi, Luigi; Lus, Giacomo; Calabrese, Massimiliano; Simone, Marta; Marfia, Girolama Alessandra; Rasia, Sarah; Cargnelutti, Daniela; Comi, Giancarlo; Zaffaroni, Mauro.
Afiliação
  • Baroncini D; Multiple Sclerosis Center, Gallarate Hospital, ASST Valle Olona, Gallarate, VA, Italy. damianobaroncini@gmail.com.
  • Ghezzi A; Multiple Sclerosis Center, Gallarate Hospital, ASST Valle Olona, Gallarate, VA, Italy.
  • Guaschino C; Dipartimento Di Scienze Della Salute, Università del Piemonte Orientale, Novara, Italy.
  • Moiola L; Multiple Sclerosis Center, Gallarate Hospital, ASST Valle Olona, Gallarate, VA, Italy.
  • Filippi M; Multiple Sclerosis Center-Neurology Department, San Raffaele Hospital IRCCS, Milano, Italy.
  • Ianniello A; Department of Neurology, Neurorehabilitation and Neurophysiology, MS Center, and Neuroimaging Research Unit, Vita-Salute San Raffaele University and San Raffaele Scientific Institute, Milan, Italy.
  • Pozzilli C; Department of Human Neurosciences, S.Andrea Multiple Sclerosis Center, Sapienza University, Rome, Italy.
  • Lanzillo R; Department of Human Neurosciences, S.Andrea Multiple Sclerosis Center, Sapienza University, Rome, Italy.
  • Brescia-Morra V; Department of Neurosciences and Reproductive and Odontostomatological Sciences, University "Federico II", Naples, Italy.
  • Margoni M; Department of Neurosciences and Reproductive and Odontostomatological Sciences, University "Federico II", Naples, Italy.
  • Gallo P; Multiple Sclerosis Centre of the Veneto Region (CeSMuV), University Hospital of Padua, Padua, Italy.
  • Callari G; Padova Neuroscience Centre (PNC), University of Padua, Padua, Italy.
  • Grimaldi L; Multiple Sclerosis Centre of the Veneto Region (CeSMuV), University Hospital of Padua, Padua, Italy.
  • Lus G; Padova Neuroscience Centre (PNC), University of Padua, Padua, Italy.
  • Calabrese M; Foundation Institute "G. Giglio", MS Center, Cefalù-Palermo, Italy.
  • Simone M; Foundation Institute "G. Giglio", MS Center, Cefalù-Palermo, Italy.
  • Marfia GA; Multiple Sclerosis Center, II Division of Neurology, Department of Clinical and Experimental Medicine, University of Campania "L. Vanvitelli", Naples, Italy.
  • Rasia S; Department of Neuroscience, Biomedicine and Movement, The Multiple Sclerosis Center of the University Hospital of Verona, Verona, Italy.
  • Cargnelutti D; Child Neuropsychiatry Unit, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
  • Comi G; MS Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy.
  • Zaffaroni M; Multiple Sclerosis Center, ASST - Spedali Civili of Brescia, Montichiari, Brescia, Italy.
Neurol Sci ; 43(11): 6415-6423, 2022 Nov.
Article em En | MEDLINE | ID: mdl-35781765

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Child / Female / Humans Idioma: En Revista: Neurol Sci Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Child / Female / Humans Idioma: En Revista: Neurol Sci Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália